Ultravist

NDC 50419-344 · Bayer HealthCare Pharmaceuticals Inc.

Generic nameiopromide

Dosage formINJECTION

RouteINTRA-ARTERIAL, INTRAVENOUS

Active ingredient(s)IOPROMIDE

Strength300 mg/mL

Pharmacologic classRadiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]

Marketing categoryNDA

Packages

50419-344-05 10 VIAL, GLASS in 1 CARTON (50419-344-05) / 50 mL in 1 VIAL, GLASS

50419-344-10 10 VIAL, GLASS in 1 CARTON (50419-344-10) / 100 mL in 1 VIAL, GLASS

50419-344-12 10 VIAL, GLASS in 1 CARTON (50419-344-12) / 125 mL in 1 VIAL, GLASS

50419-344-15 10 VIAL, GLASS in 1 CARTON (50419-344-15) / 150 mL in 1 VIAL, GLASS

50419-344-21 10 BOTTLE in 1 PACKAGE (50419-344-21) / 200 mL in 1 BOTTLE

50419-344-23 10 BOTTLE in 1 PACKAGE (50419-344-23) / 200 mL in 1 BOTTLE

50419-344-32 8 BOTTLE in 1 PACKAGE (50419-344-32) / 500 mL in 1 BOTTLE

50419-344-58 8 BOTTLE in 1 PACKAGE (50419-344-58) / 500 mL in 1 BOTTLE

50419-344-65 8 BOTTLE in 1 PACKAGE (50419-344-65) / 500 mL in 1 BOTTLE

50419-344-91 10 VIAL, GLASS in 1 CARTON (50419-344-91) / 100 mL in 1 VIAL, GLASS

50419-344-97 8 BOTTLE in 1 PACKAGE (50419-344-97) / 500 mL in 1 BOTTLE

Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Medicare Part B payment limit (ASP + 6%): $0.15

FDA lists these products with the same active ingredient.

50419-346 — iopromide, 50419-347 — iopromide, 50419-348 — iopromide

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.